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a b s t r a c t
A number of PCR-based methods for detecting human fecal material in environmental
waters have been developed over the past decade, but these methods have rarely received
independent comparative testing in large multi-laboratory studies. Here, we evaluated ten
of these methods (BacH, BacHum-UCD, Bacteroides thetaiotaomicron (BtH), BsteriF1, gyrB,
HF183 endpoint, HF183 SYBR, HF183 Taqman, HumM2, and Methanobrevibacter smithii nifH
(Mnif)) using 64 blind samples prepared in one laboratory. The blind samples contained
either one or two fecal sources from human, wastewater or non-human sources. The assay
results were assessed for presence/absence of the human markers and also quantitatively
while varying the following: 1) classification of samples that were detected but not quan-
tifiable (DNQ) as positive or negative; 2) reference fecal sample concentration unit of
measure (such as culturable indicator bacteria, wet mass, total DNA, etc); and 3) human
fecal source type (stool, sewage or septage). Assay performance using presence/absence
metrics was found to depend on the classification of DNQ samples. The assays that per-
formed best quantitatively varied based on the fecal concentration unit of measure and
laboratory protocol. All methods were consistently more sensitive to human stools
compared to sewage or septage in both the presence/absence and quantitative analysis.
Overall, HF183 Taqman was found to be the most effective marker of human fecal
contamination in this California-based study.
ª 2013 Elsevier Ltd. All rights reserved.
1. Introduction
The search for highly specific, sensitive, and cost effective
human fecal-associated PCR-based assays has been a major
focus of microbial source tracking (MST) research over the last
decade. Many new methods have emerged as a result of that
effort (Field and Samadpour, 2007; Roslev and Bukh, 2011). It is
essential that MSTmethods be able to confirm the presence of
human fecal contamination in environmental waters because
of the ubiquity of fecal indicator bacteria (FIB) in non-human
sources, knowledge gaps regarding illness risk from recrea-
tional exposure to non-human fecal sources (Boehm and
Soller, 2011), and the need to prioritize investment in waste-
water infrastructure. Previously, library-based methods were
in common use, but these were largely supplanted by PCR-
based methods following a 2003 MST method evaluation
study (Griffith et al., 2003). Until now, a large-scale multiple-
laboratory MST method evaluation study has not been con-
ducted since PCR-based methods came to the fore.
The need for confidence in the performance of human
fecal-associated MST assays has recently become more ur-
gent. The United States Environmental Protection Agency’s
new criteria for recreational water quality offer beach man-
agers the possibility of using quantitative microbial risk
assessment (QMRA) to set site-specific criteria at beaches
where the presence of human fecal pollution has been found
sufficiently small through approved MST studies. Therefore it
is crucial to robustly characterize the performance of MST
methods that may be used to determine whether a beach is
contaminated with human fecal pollution.
The most comprehensive, multiple-laboratory PCR-based
MST method evaluation study to date is described in Boehm
et al. (2013). Several important issues from this study remain
open for further exploration in the present work. First, how
does alternate classification of detectable but not quantifiable
(DNQ) samplese as positive versus non-detecte change assay
performance in presence/absence metrics? DNQ data
handling often presents a trade-off between sensitivity and
specificity, and as there is currently no consensus in the field
regarding how to handle DNQ samples, it is important to
consider both approaches when judging assay performance.
Secondly, how did the assays perform, both qualitatively and
quantitatively, under all available challenge filter sample
units of measure? Characterization of challenge sample fecal
concentrations in different terms (such as 1mg of wet feces or
1 ng of total DNA) may produce variable performance results,
and every available characterization of the samples should be
considered in order to comprehensively compare perfor-
mance among assays. Third, how did the source of “target”
sample (human stools, sewage, or septage) influence assay
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performance? Several factors may affect the performance
assessment of these targets, including different states of
decay and potential presence of non-human bacteria in
wastewater; thus, it is important to evaluate these “target”
sources separately. Lastly, how did the human-associated
assays perform with mixed-source samples? The
“doubleton” samples all contained a human stool, sewage, or
septage “target” source plus a non-human fecal source, and
thus offered the unique opportunity to investigate human-
associated assay sensitivity in the presence of non-target
feces.
The present work seeks to fill the above gaps by consid-
ering each of these issues in detail. Accordingly, the goals of
this paper are to evaluate the performance of ten human fecal
anaerobe-associated PCR-based assays under varying char-
acterizations of: 1) DNQ samples; 2) the challenge filter sample
concentration unit of measure; and 3) the human “target”
samples; and to evaluate the effect of combining human and
non-human fecal sources in a sample.
2. Methods
2.1. Sample creation and analysis
Briefly, 64 blind challenge samples were created by mixing
fresh feces (from chicken, cow, dog, deer, goose, gull, horse,
human, pig, or pigeon), sewage, or septage in artificial fresh-
water. All fecal, sewage and septage samples were obtained
from various sites across California. The filter set included 19
single-source (“singleton”) and 13 mixed-source (“doubleton”)
samples in duplicate. Each doubleton sample contained
human stools, septage, or sewage combined with one non-
human fecal source. Detailed methods for the creation of
the challenge filter samples can be found in Boehm et al.
(2013).
Seventeen laboratories from the United States and the
European Union contributed data to the study. The assay
naming conventions used here generally follow the original
publications (Table 1). The number of laboratories that per-
formed each method is as follows: BacH (1), BacHum-UCD (6),
BsteriF1 (4), BtH (1), gyrB (1), HF183 endpoint (7), HF183 SYBR
(4), HF183 Taqman (5), HumM2 (6), and Mnif (5). The labora-
tories used six different DNA extraction methods: GeneRite
DNA-EZ (12), Qiagen DNeasy (1), Qiagen QIAamp (1), MP
Biomedicals FastDNA SPIN (1), MoBio PowerWater (1), and
phenol:chloroform extraction (1). Five laboratories involved in
planning the study agreed to standardize their methods of
DNA extraction (GeneRite DNA-EZ ST) and quantification
(NanoDrop), q/PCR chemistries (Applied Biosystems TaqMan
Universal PCR Master Mix or TaKaRa Ex Taq with original
authors’ primer/probe concentrations), and data processing
(described in detail in Ebentier et al. 2013). These standardized
operating protocols (SOPs) were made available to all partici-
pating laboratories, but adherence to the protocols was not
required. Details of the laboratory SOPs and supply vendors
are provided in the Supplemental Information (Section 1 and
Tables S1eS2). All data analyses in the present work were
performed in R (v 2.14.0) with RStudio (v 0.96). Details of each
analysis are described below.
2.2. Classification of DNQ
The presence/absence sensitivity and specificity metrics were
calculated in two ways: once with DNQ (detected, not quan-
tifiable) samples considered positive and a second time with
DNQ considered negative. All laboratories’ datawere analyzed
together as one dataset and only the singleton (single-source)
samples were included (every doubleton contained both a
human and non-human fecal source, so it was not possible to
independently evaluate sensitivity and specificity in the
doubletons). All positive results for the endpoint assay were
considered DNQ. The lower limit of quantification (LLOQ) for
qPCR assays was defined for each laboratory as the lowest
concentration on the standard curve where amplification was
observed in at least 50% of qPCR replicates. The LLOQ values
for each laboratory and assay are listed in Table S3. For sam-
ples within the range of quantification, the reported copy
numbers were used. Samples with a quantification threshold
cycle (Cq) greater than the laboratory-specific LLOQ were
classified as DNQ regardless of how these samples were
originally reported. DNQ samples were assigned a value of 150
copies/filter for quantitative analyses. This value was based
on three assumptions: 1) a theoretical minimum detection
limit of 3 copies per reaction (Bustin et al., 2009); 2) 2 ml tem-
plate total DNA per reaction; and 3) 100 ml of DNA extract per
filter. Assumptions 2 and 3 were valid for most laboratories
and assays. Sensitivity and specificity metrics were calculated
using the same equations and benchmarks described by
Boehm et al. (2013).
2.3. Challenge filter sample units of measure
The following units of measure were used to normalize the
singleton qPCR data: wet mass, total DNA, Enterococcus CFU,
Escherichia coli CFU, Enterococcus qPCR (Haugland et al., 2005), E.
coli 23S qPCR (Chern et al., 2011), and “general” Bacteroidales
qPCR by GenBac3 (Siefring et al., 2008), AllBac (Layton et al.,
2006), BacUni-UCD (Kildare et al., 2007), B. fragilis group
(Matsuki et al., 2002), and fecal Bacteroides (Converse et al., 2009).
The fecal source characterizations presented in Ervin et al.
(2013) were used for wet mass, Enterococcus CFU, E. coli CFU,
and E. coli 23S qPCR. Total DNA mass data were obtained from
the laboratories: a majority (13 of 17) measured total DNA
concentrations on each filter with a NanoDrop spectropho-
tometer. When values for total DNA yield were reported as
negative, “too low” or some other indication of data below the
detection limit, a value of 1 ng/filter was substituted. Paired
measurements (of human assay targets and DNA mass) per
filter were used to normalize the data. Some laboratories
measured and reported “general” qPCR assay characterizations
of the samples, including Entero1A (5), GenBac3 (3), AllBac (1),
BacUni-UCD (1), B. fragilis group (1) and fecal Bacteroides (1). The
general assay data were used to normalize the human-
associated qPCR data from those laboratories using paired
measurements (of human and general assay targets) per filter.
For each of the above units of measure, the assay with the
highest gene copy abundance among target samples (human
stools, sewage and septage taken together) was considered the
most sensitive, and the assay with the largest difference in
median gene copy abundance between target and non-target
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Table 1 e Summary of original assay developer’s publications.
Assay Reference Target gene Oligo names Reference
material
(standards)
Test
material
(target)
Challenge material
(non-target)
Challenge quantity
(per reaction)
LLOQ (quantity
per reaction)
Sensitivity Specificity
BacH Reischer
et al. (2007)
Bacteroides 16S BacHf, BacH-pT,
BacH-pC,
BacHr
Plasmid Human,
sewage,
cesspits
Cattle, Deer, Chamois,
Roe deer, Sheep, Goat,
Horse, Fox, Dog, Cat, Pig,
Chicken, Turkey, Swan,
Duck, Black grouse
1 mg wet wt 30 copies 98% 98%
BacHum-
UCD
Kildare
et al. (2007)
Bacteroides 16S BacHum160f,
BacHum193p,
BacHum241r
Plasmid Human,
sewage
Cow, horse, dog, cat,
seagull
5000 copies
BacUni-UCD
30 copies 100% 87%
BsteriF1 Haugland
et al. (2010)
B. stericoris 16S BsteriF1DE, BthetP1,
BthetR1
Plasmid Human,
sewage
Cattle, Pig, Chicken,
Dog, Cat
1 ng fecal DNA 10 copies 100% NRa
BtH Yampara-Iquise
et al. (2008)
B. thetaiota-omiron
a-1-6 mannanase
BtH-F, BtH-P, BtH-R Genomic B.
thetaiota-
omicron DNA
Human,
sewage
Dogs, Beef cattle, Dairy
cattle, Horses, Swine,
Goose, Chickens, Turkeys
1 ng fecal DNA 9.3 copies 100% 100%
gyrB Lee and Lee
(2010)
B. fragilis gyrB Bf904F, Bf923MGB,
Bf958R
Genomic
B. fragilis
DNA
Human Cow, Dog, Pig 10 ng fecal DNA 1.1*102 copies 100% 97%
HF183
endpoint
Bernhard and
Field (2000)
Bacteroides 16S HF183F, Bac708R Plasmid Human,
sewage
Cat, cow, deer, dog, duck,
elk, goat, llama, pig,
seagull, sheep
2e4 ng fecal DNA 1.4*106 g/L
dry sewage
88% 100%
HF183 SYBR Seurinck
et al. (2005)
Bacteroides 16S HF183F, HFsybR Plasmid Human,
sewage
Chicken, cow, dog,
horse, pig
2.2 mg wet wt 2.8*102 copies 91% NRb
HF183
Taqman
Haugland
et al. (2010)
Bacteroides 16S HF183F, BthetP1,
BthetR1
Plasmid Human,
sewage
Cattle, Pig, Chicken,
Dog, Cat
1 ng fecal DNA 10 copies 100% NRc
HumM2 Shanks et
al. (2009)
B. fragilis
hypothetical
protein BF3236
HumM2F, HumM2P,
HumM2R
Plasmid Human,
sewage
Alpaca, Cow, Goat, Sheep,
Horse, Pig, Antelope,
Whitetail deer, Mule deer,
Moose, Elk, Canadian Goose,
Duck, Pelican, Gull, Turkey,
Chicken, Marine dolphin,
California sea lion, Cat, Dog
1 ng fecal DNA 10 copies 100% 99%
Mnif Johnston
et al. (2010)
Methanobrevibacter
smithii nifH
Mnif202F, MnifP,
Mnif353R
Genomic
M. smithii
DNA
Sewage Gull, ambient seawater 15 mg wet wt 5 genome
equivalents
100% 72%
a Not reported; strong cross-reaction with cat, dog.
b Not reported; cross-reaction with one chicken.
c Not reported; weak cross-reaction with chicken, dog.
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samples was considered themost specific. Note that these per-
formance metrics differ from those used in Boehm et al. (2013).
Because performance outcomes can change under
different characterizations of fecal concentration, it was
necessary to select a primary unit of measure by which to
judge quantitative assay performance. We chose to focus on
total DNA mass on each challenge filter as measured by
NanoDrop spectrophotometry. We defined quantitative
benchmarks for sensitivity and specificity based on copies per
nanogram of total DNA: an assay was quantitatively sensitive
if themedian abundance in every target source (human stools,
sewage and septage considered separately) was greater than
10 copies/ng, and an assay was quantitatively specific if the
interquartile ranges of copies/ng did not overlap between
target and non-target sources.
To study the effect of challenge filter sample units of
measure on the presence/absence performance metrics, we
chose a balanced subset of the data and performed an in silico
dilution experiment. This subset consisted of assays run by
the method developer’s laboratory (BacH, BacHum-UCD,
BsteriF1, gyrB, HumM2, HF183 Taqman and Mnif). In this
subset, the assays were performed under optimal conditions
(in the hands of their developer’s lab) and the n for all assays
was the same. Presence/absence method performance in this
subset was evaluated using the same challenge filter sample
units of measure that the method developers used when the
assays were first published (Table 1). This was done by in silico
dilution or addition of the appropriate amount of fecal mate-
rial and calculating what the copy numbers would have been
based on the observed amplification with the actual challenge
filter samples. For this exercise, a limit of detection (LOD) of 10
copies per reaction was applied: amplification below this level
was considered negative and anything above 10 copies was
considered positive.
2.4. Doubleton analyses
To determine the effect of mixed fecal sources on assay per-
formance, sensitivity was evaluated in the doubleton samples
with respect to the non-human source present and the esti-
mated relative contributions of total DNA from each source.
The proportion of total DNA contribution from each fecal
source was estimated using a mass ratio approach. The me-
dian NanoDropmeasurements on the singleton samples were
multiplied by the volumetric proportions used to create the
doubleton samples (see Boehm et al. (2013) for sample crea-
tion details), and the ratio of target:non-target DNA on each
doubleton filter was estimated from those values. Presence/
absence sensitivity (with DNQ values considered positive) was
calculated for every assay according to doubleton type and
compared to the target:non-target DNA ratios.
3. Results
3.1. Performance by DNQ classification
None of the assays met the 80% benchmark used by Boehm
et al. (2013) and the USEPA (2005) for both specificity and
sensitivity when DNQ was considered positive (Table 2). With
DNQ negative, BtH, HF183 SYBR and HF183 Taqman met the
benchmark for both sensitivity and specificity metrics. Assay
sensitivity was high but specificity was low when DNQ results
were regarded as positive. All assays except HF183 endpoint
and Mnif were at least 80% sensitive with DNQ positive. The
only assay that was at least 80% specificwith DNQ positivewas
HF183 endpoint; however, HF183 SYBR, BacH and HumM2were
not appreciably behind the mark at 78%, 77% and 75%,
respectively. When DNQ was negative, sensitivity decreased in
all assays except BacHum-UCD, and all assays were considered
specific except BacHum-UCD, BsteriF1 and Mnif. Note that the
results presented in Table 2 use a “per filter” characterization of
presence/absence in the challenge filter samples and consider
all laboratories’ data together as one dataset.
3.2. Performance by challenge filter sample unit of
measure
The presence/absence specificities of HF183 Taqman and
BacHum-UCD under their developer’s challenge filter sample
units of measure were starkly different from the “per filter”
specificity results (both 96% in developers’ lab versus 46% and
37% across all labs, respectively, DNQ positive). In general, the
assays performed well with their developers’ execution and
test sample quantities (Table 3). However, in our study the
assays often performed worse than reported in their original
publications (Table 1), except for BacHum-UCD under its
original challenge sample units of measure (Table 3). Inter-
estingly, BacHum-UCD was the only assay that showed
excellent sensitivity using the units of 5000 copies of BacUni-
UCD per reaction, which was the benchmark used to develop
the BacHum-UCD assay (Kildare et al., 2007).
When the challenge filter samples were characterized by
total DNA mass and all laboratories’ data were analyzed
Table 2 e Performance of human-associated assays in
singleton samples among all labs, calculated with DNQ
(detected, not quantifiable) samples as positive or
negative, with presence/absence determined on a per-
filter basis.
Assay Sensitivity Specificity
Human
na
DNQþ DNQ Non-
human na
DNQþ DNQe
BacH 12 100% 75% 26 77% 85%
BacHum-
UCD
72 97% 97% 156 37% 67%
BsteriF1 48 100% 96% 104 44% 61%
BtH 12 100% 92% 26 54% 96%
gyrB 12 92% 50% 26 58% 96%
HF183
endpoint
84 75% NA 182 96% NA
HF183
SYBR
48 100% 92% 104 78% 89%
HF183
Taqman
60 100% 95% 130 46% 92%
HumM2 72 93% 67% 156 75% 94%
Mnif 60 78% 60% 130 68% 76%
a Values for n vary among assays because the methods were per-
formed by different numbers of laboratories; see Section 2.1.
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together, HF183 Taqman was the only assay categorized as
both quantitatively sensitive and specific (Fig. 1). The four
assays targeting functional genes (BtH, gyrB, HumM2 and
Mnif) were less sensitive than the assays targeting the Bac-
teroides 16S rRNA gene, likely due to fewer copies of the
functional genes per cell. All assays were considered quanti-
tatively sensitive except BtH, HumM2, and Mnif, while only
HF183 Taqman and BtH were considered specific. Dog was a
frequent source of false positives: BacH, BacHum-UCD and
BsteriF1 had cross-reactivity in dog samples at levels equiva-
lent to that of sewage/septage (BacH, BacHum-UCD) or human
stools (BsteriF1). BacH cross-reacted with the fewest number
of non-human sources (only dog and deer).
When gene copy abundance of each quantitative assay in
the singleton samples was normalized to all available fecal
source units of measure, it was clear that which assay per-
formed best was dependent on how the challenge samples and
performancemetrics were defined (Table 4). BacHum-UCDwas
1
100
10000
BacH (1) BacHum−
UCD (6)
BsteriF1 (4) BtH (1) gyrB (1) HF183
SYBR (4)
HF183
Taqman (5)
HumM2 (6) Mnif (5)
Assay
Co
pi
es
 p
er
 n
g 
to
ta
l D
NA
Source
chicken
cow
deer
dog
goose
gull
horse
human
pig
pigeon
septage
sewage
Fig. 1 e Copies per nanogram total DNA in each fecal source for quantitative assays. Each point is the median value for a
given source, and the bars represent the interquartile ranges (25th to 75th percentiles). Fecal sources are indicated by a
unique combination of color and shape. The solid markers are “target” sources (human stools, sewage or septage). The
dashed horizontal line indicates 10 copies per nanogram, which we used as a benchmark of assay sensitivity. The numbers
in parentheses after each name on the x-axis indicate the number of labs that performed the assay.
Table 3e Sensitivity and specificity of human qPCR assays in singleton samples, calculated using original developer’s data
generated in this study and the developers’ original challenge fecal sample units of measure. Developers’ ownmetrics are
shown in bold.
Assay Sensitivity Specificity
na 1 mg wet
mass
15 mg wet
mass
5000 copies
BacUni-UCD
1 ng
DNA
10 ng
DNA
nb 1 mg wet
mass
15 mg wet
mass
5000 copies
BacUni-UCD
1 ng
DNA
10 ng
DNA
BacH 12 100% 100% 42% 75% 92% 26 77% 77% 100% 88% 85%
BacHum-
UCD
12 100% 100% 100% 100% 100% 26 62% 54% 96% 65% 65%
BsteriF1 12 100% 100% 0% 100% 100% 26 46% 42% 92% 77% 58%
gyrB 12 100% 100% 0% 58% 75% 26 69% 58% 100% 100% 88%
HF183
Taqman
12 100% 100% 17% 100% 100% 26 62% 42% 96% 96% 73%
HumM2 12 100% 100% 0% 58% 83% 26 92% 81% 100% 100% 92%
Mnif 12 100% 100% 17% 75% 83% 26 77% 77% 100% 81% 81%
a Number of target (human stool, sewage or septage) samples in the analysis.
b Number of non-target (non-human animal) samples in the analysis.
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Table 4 e Human-associated marker abundance under all available fecal source characterizations. Values are median (standard deviation) of log10-transformed copy
numbers across all labs. Underline indicates the most sensitive assay (largest copy abundance in target samples) and bold indicates the most the specific assay (largest
difference in median copy abundance between target and non-target) for each unit of measure.
Assay Source n MgWetc DNAd ENT
MFe
ENT qPCRf E. coli
MFg
E. coli qPCRh GenBac3i AllBacj BacUni-UCDk Bfragl FecalBm
BacH Targeta 12 7.5 (0.2) 1.9 (2) 2.1 (1.8) e 1.5 (0.9) 0.6 (0.9) e e e e e
Non-targetb 26 2.8 (0.9) 0.9 (0.9) L1.5 (1.8) e 1.5 (1.2) 2.2 (0.9) e e e e e
BacHum-UCD Target 72 7.1 (1) 2.7 (1.7) 3 (1.3) 0.4 (1.5) 1.9 (1.1) 1 (0.9) 1.2 (0.4) e 0.4 (0.2) e e
Non-target 156 2.4 (1.7) 0 (1.7) L0.6 (1.3) 2.9 (1.3) 1.3 (1.8) 2.2 (1.7) 3.9 (1.9) e 3.8 (2.3) e e
BsteriF1 Target 48 6.8 (0.2) 2 (1.5) 2.3 (1.1) 0.3 (1.6) 1.4 (0.6) 0.5 (0.3) 1.6 (0.5) e e e e
Non-target 104 2.9 (2) 0.8 (2) 0.7 (1.4) 1.8 (2.1) 1.3 (2) 2.2 (2.1) 3.6 (1.8) e e e e
BtH Target 12 5.3 (0.1) 1 (1.4) 1.4 (0.9) 0.2 (1.9) 0.2 (0.9) L0.6 (0.5) e e e e e
Non-target 26 0.9 (0.7) 0.9 (0.4) 1.1 (1.2) 2.8 (1.2) 3.7 (1.6) L4.3 (1.2) e e e e e
gyrB Target 12 5.2 (0.3) 1.5 (1.4) 0.8 (1.1) e 0.2 (0.6) 1.1 (0.5) e e e 2 (0.7) e
Non-target 26 1.2 (0.8) 0.3 (0.6) 0.9 (1.5) e 2.8 (1.1) 3.5 (0.8) e e e 3.4 (1.2) e
HF183 SYBR Target 48 5.9 (1.1) 1.7 (1.5) 1.9 (1.4) 0.9 (1.5) 0.5 (1.3) 0.2 (1.2) 2.2 (0.8) 2.1 (0.3) e e 1.5 (0.5)
Non-target 104 2.3 (1) 0.2 (0.8) 0.9 (1.4) 3.7 (1.3) 2.1 (1.4) 3.2 (1.3) 5.4 (1.9) 5.1 (NA)n e e NA (NA)o
HF183 Taqman Target 60 6.9 (0.1) 2.2 (1.5) 2.4 (1.1) L0.3 (1.7) 1.3 (0.6) 0.5 (0.3) L1.7 (0.6) e e e e
Non-target 130 1.2 (0.9) L0.5 (0.8) 1.1 (1.5) L4 (1.3) L2.8 (1.4) L3.2 (1.1) L5.1 (2.1) e e e e
HumM2 Target 72 5.3 (0.3) 0.9 (1.4) 1.1 (1) 1.6 (1.7) 0.2 (0.7) 0.8 (0.5) 2.9 (0.7) e e e e
Non-target 156 0.8 (0.9) 1.1 (0.7) 0.9 (0.8) 3.7 (1.3) 2.6 (1.2) 3.2 (0.7) 6.2 (1.9) e e e e
Mnif Target 60 5.7 (0.5) 1.3 (1.6) 2 (1.2) 2.3 (2.1) 0.2 (1.1) 0.5 (0.9) 3.1 (0.8) e e e e
Non-target 130 3.4 (1.2) 0.8 (1.3) 1.6 (2.2) 1.9 (2.2) 0.7 (1.9) 1.3 (1.7) 4.5 (1.3) e e e e
a Human stools, sewage and septage.
b non-human animals.
c mg wet mass, sewage and septage samples excluded.
d ng total DNA by NanoDrop.
e EPA method 1600.
f Entero1(A) (Haugland et al., 2005).
g E. coli membrane filtration.
h E. coli 23S qPCR assay EC23S857 (Chern et al., 2011).
i (Siefring et al., 2008).
j (Layton et al., 2006).
k (Kildare et al., 2007).
l B. fragilis group specific (Matsuki et al., 2002).
m Fecal Bacteroides (Converse et al., 2009).
n n of samples with amplification was too small to calculate standard deviation.
o No amplification was observed.
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the most sensitive assay using the total DNA mass, E. coli CFU,
E. coli qPCR and GenBac3 measurements. BtH was the most
sensitive assay using the Enterococcus qPCR copy units, but was
less sensitive in other quantitative measures. BacH was the
most sensitive assay only under the wet mass unit of measure,
which was the same fecal unit used to develop that assay.
HF183 Taqman was the most specific assay in six of the seven
units of measure where it was possible to make a comparison:
milligrams of wet feces, mass of total DNA, E. coli CFU, E. coli
qPCR, Enterococcus qPCR, and GenBac3. The only fecal source
characterization for which HF183 Taqman was not the most
specific assay was Enterococcus CFU, where BacHum-UCD
excelled.
3.3. Performance by target source
The sensitivity of each assay differed for each of the three
“target” sources: human stools, sewage and septage. In almost
every case, sensitivity was greatest in human stools, followed
by septage, and least sensitive in sewage samples (the
exception was gyrB, which had greater sensitivity in sewage
Table 5 e Sensitivity of human-associated assays in
singleton human, sewage and septage samples
calculatedwith detected, not quantifiable (DNQ) values as
positive or negative on a per-filter basis.
Assay na Human Sewage Septage
DNQþ DNQe DNQþ DNQe DNQþ DNQe
BacH 4 100% 100% 100% 50% 100% 75%
BacHum-
UCD
24 100% 100% 92% 92% 100% 100%
BsteriF1 16 100% 100% 100% 88% 100% 100%
BtH 4 100% 100% 100% 75% 100% 100%
gyrB 4 100% 100% 100% 50% 75% 0%
HF183
endpoint
28 96% NA 57% NA 71% NA
HF183 SYBR 16 100% 100% 100% 81% 100% 94%
HF183
Taqman
20 100% 100% 100% 85% 100% 100%
HumM2 24 100% 100% 83% 46% 96% 54%
Mnif 20 95% 95% 55% 20% 85% 65%
a Number of singleton samples in each target source (varies by
number of laboratories running each assay).
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Fig. 2 e Presence/absence per-filter sensitivity (DNQ positive) in doubletons versus the estimated target:non-target DNA
ratio. The three target sources present in the doubletons are organized into the horizontal panels. The shape of each point
indicates the non-target source in the doubleton, and the assays are differentiated by colors. The size of each point indicates
the number of measurements that were used to calculate the sensitivity value for that point, which ranged from 2 to 14. The
horizontal positions of the points were “jittered” to make more of the data visible. The dashed lines represent the lowest
sensitivity of any assay in the target singletons (DNQ positive).
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than septage; Table 5). The presence/absence metrics were
also greatly dependent on DNQ classification. With DNQ
positive, five assays were perfectly sensitive (100%) to all three
target sources: BacH, BsteriF1, BtH, HF183 SYBR and HF183
Taqman. No assay was 100% sensitive to all three targets with
DNQ negative, though BacHum-UCD, BsteriF1, HF183 SYBR
and HF183 Taqman met the 80% benchmark. In quantitative
terms, every assay was orders of magnitude more sensitive
(by copies per nanogram of total DNA) to human stools than to
septage or sewage (Fig. 1). BacH was the most sensitive of all
assays to human stools, and BacHum-UCDwasmost sensitive
of all assays to sewage and septage.
3.4. Performance in doubleton samples
In the doubletons containing sewage, a decrease in
target:non-target DNA ratio appeared to decrease sensitivity
in the samples containing gull feces (bottompanel, Fig. 2). This
change was especially noticeable for Mnif, HumM2, gyrB and
HF183 SYBR. Sensitivity was also low in the chicken/sewage
samples for Mnif and HF183 endpoint. For the doubleton
samples containing human stools (top panel), sensitivity
remained consistently high; only HF183 endpoint showed a
slight decrease in sensitivity at lower target:non-target DNA
ratios. The doubletons containing septage consisted of only
one sample type: 10% septage:90% horse. For these samples,
all assays were considered sensitive except Mnif.
4. Discussion
4.1. DNQ classification
The classification of DNQ samples as positive or negative
dramatically affected the performance of the assays in pres-
ence/absence metrics, and this has important implications for
local beach management applications. Changing the DNQ
classification from positive to negative decreased sensitivity
slightly but improved specificity substantially for all assays
(Table 2). The assays that were judged as acceptably sensitive
or specific with the presence/absence metrics differed slightly
from Boehm et al. (2013) because here we considered only
singletons and pooled all labs’ data together. However, variable
performance was observed among laboratories and this vari-
abilitymay skew the overall DNQ classification results (Fig. S1).
The variable results among laboratories may be a product of
the different LLOQvalues obtained by using different types and
quantities of standard reference material, Cq threshold set-
tings, and other variations in method protocols.
The treatment of DNQ samples in the MST literature is
mixed. For example, some studies have definedDNQ values as
negative (Stapleton et al., 2009), while others have regarded
DNQ amplification as a positive detection (Kelty et al., 2012);
still others established a lower limit of detection for the qPCR
but did not differentiate between LLOQ and LOD (Sauer et al.,
2011). For SYBR assays, most groups consider DNQ samples
negative, due to the difficulty in validating melt curves for
such low amplification. Information on DNQ handling is often
not reported at all. To our knowledge, this work and the other
manuscripts from the present study (Raith et al., 2013;
Sinigalliano et al., 2013) are the first to comprehensively
examine the effects of varying DNQ classification on MST
assay performance.
In our analysis, we found that assay specificity was supe-
rior when DNQ results were treated as negative. One possible
explanation is that most human-associated genetic markers
are not strictly found in human sources; instead, they are
typically found at a higher abundance in human sources
(Shanks et al., 2010). Thus, the more sensitive the method is,
themore likely it is that cross-reactivitywill be observed in the
DNQ range. In environmental samples, DNQ measurements
may result from dilution or degradation of a human fecal
source or from cross-reactivity. Experts in the field have not
yet reached consensus regarding how to classify DNQ results
obtained in MST field studies (Stewart et al., 2013). In practice,
it may be beneficial to perform both a human bacteria-
associated assay (highly sensitive, less specific) and a
human viral assay (highly specific, less sensitive); however,
the optimal method for concentrating human viruses from
environmental water samples is yet to be determined (see
Harwood et al., 2013).
4.2. Challenge filter sample units of measure
The amount of fecal matter on a filter can be described using
several units of measure, and we found that changing the
challenge filter sample units of measure can change which
assays performed best. The relative quantities of fecal mate-
rial in our challenge filter samples changed considerably
among fecal sources when different units of measure were
used to describe fecal concentrations. For example, one fecal
source may have low Enterococcus levels, but a high wet mass
compared to another source (Ervin et al. 2013). Accordingly,
the assay that performed best on a “per unit” basis depended
on which unit of measure was used. Data from all labs were
used in this analysis, even though there were differing sizes of
datasets and clear lab-to-lab variation (see Section 4.6), and
our results should be interpreted with those factors in mind.
To our knowledge, the present work and other manuscripts
from this study (Boehm et al., 2013; Raith et al., 2013;
Sinigalliano et al., 2013) are the first to examine the effects
of changing fecal units of measure on the performance out-
comes of molecular MST methods.
We focused on total DNA mass as the primary challenge
filter sample unit of measure. The amount of fecal matter
varied substantially from filter to filter, both within a given
fecal sourceandacross sources (Ervinet al., 2013), yet itwasnot
possible to directly quantify the fecalmaterial on each filter for
every unit of measure. Total DNA mass was the only unit of
measure with measurements on individual filters using the
same quantification method from a majority of laboratories
(832 total DNA measurements). Further, because total DNA
yield varied extensively among laboratories (Figure S2),
normalizing to totalDNAminimizedbias andput theassayson
the most level playing field possible (see Kelty et al., 2012).
When the data were normalized to ng total DNA, HF183
Taqman was the only assay categorized as both sensitive and
specific. Numerous studies from around the world have
demonstrated the success of the original HF183 endpoint PCR
assay (e.g. Griffith et al., 2003; Gawler et al., 2007; Ahmed et al.,
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2012), andmanyqPCRassayshavebeendeveloped to target the
same region of the Bacteroides 16S rRNA gene (see Supple-
mental Information). In the present work, the HF183 endpoint
assay wasmuch less sensitive to sewage than the HF183 qPCR
assays (Table 5), suggesting that a qPCR version of thismethod
is preferable where sewage contamination is a concern.
4.3. Influence of target source
Assay sensitivity varied among the three “target” sources
(human stools, sewage or septage). While every assay was
highly or perfectly sensitive to human stools, successwasmore
varied with sewage and septage sources. There are several
possible explanations. Firstly, the sewage and septage chal-
lenge filter samples had very low quantities of fecal material
compared to thehuman stool samples (Ervin et al., 2013), which
affects sensitivity on a “per filter” basis. Secondly, sewage and
septage are mixed sources with fecal inputs from humans as
well as other animal species. Themixednature of these sources
could affect sensitivity both in terms of decreased amount of
target per unit of fecal material as well as possible cross-
reactivity to the non-human inputs. Lastly, the assays in this
studywere initially designed to be human fecal-associated, not
necessarily sewage or septage-associated (though many were
validatedwith sewage samples). Given the differences between
stool samples and sewage/septage, there is a need for methods
that can discriminate sewage and septage, such as community
analysis (Cao et al., 2013). In consideration of the differences
among target sources, Table 4 was recreated with the stool and
sewage/septage target sources analyzed separately (Table S4).
Almost every assay had lower sensitivity to sewage than
septage (Table 5, DNQ negative). Septic tanks may be more
hospitable environments for fecal anaerobes than sewerage
systems, and thus the microbes targeted by the assays in this
study may be more numerous in septage samples than
sewage. This hypothesis is supported by the greater copy
numbers of general Bacteroidales per total DNA mass
observed in septage versus sewage samples (Fig. S3). Further,
it has been previously shown that septage has higher con-
centrations than sewage of E. coli uidA, Enterococcus 16S rRNA
and BtH gene copies (Srinivasan et al., 2011), and that only a
small percentage of microorganisms in sewage are fecal-
derived (McLellan et al., 2010).
Our findings contrast with those of some of the original
assay publications. For example, Kildare et al. (2007) found the
BacHum-UCD marker to be less prevalent in human stools
than wastewater samples, though gene copy abundance in
these sources was not reported. Similarly, researchers in
France found HF183 SYBR to be less prevalent in stools than
wastewater (Mauffret et al., 2012). In the present study,
HumM2 and HF183 Taqman were orders of magnitude less
sensitive to sewage but substantially more abundant in
human stools than reported by Shanks et al. (2009, 2010).
The discrepancies between our results and those of previ-
ous studiesmay due to differences in thewastewater samples.
In the present work, we sampled a relatively small number of
treatment plants (n ¼ 9), some of which receive industrial
wastewater (up to 20% of total input volume and as much as
50% during certain times of day; C. McGee, pers. comm.).
Stapleton et al. (2009) found several orders ofmagnitude fewer
gene copies of human Bacteroides in industrial wastewater
compared to sewage. In addition, the microbial community
present in the sewerage infrastructure (biofilms) may be quite
different among locations due to a number of factors. Thus it is
possible that the microbial profile of the sewage influent used
in the present study may vary considerably from those found
elsewhere, which could explain some of the contrasting re-
sults. Before thesemethods are employed in localMST studies,
management agencies may benefit from performing small
studies to establish the assays’ sensitivity to the wastewater
sources present in their watersheds.
4.4. Doubletons
In environmental water samples, there will be numerous
sources of bacterial DNA, including multiple fecal hosts and
indigenous microbes. The doubleton challenge samples repre-
sent an idealized model of very a simple two-host system. In
our analysis,weuncovered an interesting effect of gull feces on
sensitivity to sewage (Fig. 2). It appears that gull fecesdecreased
sensitivity to sewage in several assays, yet this effect was not
observed in the sewage/pig samples or in the human/gull
samples. To our knowledge, no other method evaluation
studies have tested these assays against a sewage/gull matrix.
This finding has implications for application of these assays at
beaches with large native seagull populations; however, not
every assay was affected and the number of samples in this
category was relatively small. Further study is needed before
definite recommendations can be made on this issue.
4.5. Effect of individual laboratory performance
An important source of variability in assay performance is the
effect of individual laboratories, whether due to differing
protocols or varying levels of experience with the technology.
The sources of inter-laboratory variability in assay perfor-
mance include: DNA purification approach and efficiency,
DNA yield measurements, qPCR chemistry, type of qPCR
standard reference material, qPCR instrument, laboratory
infrastructure (i.e. spatial separation of tasks) and technician
skill level. Even with standardized protocols, laboratories may
produce different results (Pan et al., 2010). In the present
study, there are several instances of assay performance
differing across laboratories (Fig. S1). These differences are
often driven by DNQ classification, which reflects the varying
LLOQ values among laboratories (Table S3). Issues associated
with repeatability among laboratories in this study are
explored in depth in Ebentier et al. (2013). It is clear that SOPs
e which should include everything from laboratory setup to
data handling and stringent quality assurance guidelines e
must be established for accurate performance assessment
and successful implementation of these methods.
Another important limitation of this work is the imbalance
in size of the datasets between assays (ranging from 1 to 7
laboratories), which creates a statistical bias in the perfor-
mancemetrics. This bias is exacerbated by the clear lab-to-lab
variability in performance. This bias and variability make it
difficult to compare performance metrics across assays, and
could be why the overall performance in the present study
often does not match the original reports. Method
wat e r r e s e a r c h 4 7 ( 2 0 1 3 ) 6 8 9 7e6 9 0 86906
performance needs to be determined with an unbiased data-
set where lab-to-lab variability is not a factor (e.g. Table 3).
5. Conclusions
 HF183 Taqman consistently excelled across numerous per-
formance benchmarks
 In practice, it may be beneficial to use two assays targeting
different genes and/or bacterial species, such as HF183
Taqman with BtH or HumM2
 Further work is needed to determinewhether the additional
uncertainty associated with using multiple human-
associated assays adds value to source tracking efforts
 While these assays performed well with fresh fecal pollu-
tion sources from California in an artificial water source,
several issues still need to be thoroughly addressed prior to
implementation in local management settings: persistence
and decay, standardization of protocols, performance with
reference feces from different geographical areas and ani-
mal species, and potential influence of the environmental
sample matrix on amplification
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Performance of Human Fecal-Associated PCR-Based Assays in a Multi-Laboratory 
Method Evaluation Study (Layton et al.): Supplemental Information 
 
1. Standard Operating Procedures (SOPs) used by “core” SIPP laboratories 
1.1. Five laboratories involved in planning the SIPP study (SCCWRP, Stanford University, 
UC Santa Barbara, UCLA, and US EPA/Shanks, collectively known as the “core” labs) 
agreed to standardize their protocols for DNA extraction, DNA quantification, q/PCR, 
and data analysis. These SOPs were shared with all participating laboratories, but 
adherence to these SOPs was optional. All core labs and four “outside” laboratories used 
the GeneRite DNA-EZ ST kit for DNA extraction. All core labs and eight outside 
laboratories used a NanoDrop spectrophotometer for DNA quantification. Four core labs 
also quantified DNA using a fluorescence-based kit (Quant-iT), but only NanoDrop data 
were used in the analysis for this manuscript. Detailed protocols for q/PCR are found in 
Table S1. Manufacturer and vendor information for q/PCR reagents are found in Table 
S2. The SIPP SOP for using the FlashGel system to visualize conventional PCR 
products is given in Section 1.2 below. Details of data analysis are described in Ebentier 
et al. (this issue). Briefly, all core laboratory qPCR data (from both human and general 
assays) were quantified using lab-specific standard curves. These lab-specific curves 
were generated by pooling data from standard curves run on each qPCR plate, as well as 
a “master” standards plate containing triplicates of four separate dilution series. The 
lower limit of quantification (LLOQ, copies per reaction) was defined as the lowest 
point on the standard curve for which >50% of the replicates amplified. When samples 
had amplification in <3 PCR triplicates, a Cq of 40 was substituted for the non-detect 
replicates and the sample mean of 3 Cq values was used to quantify the copies present in 
the sample. Outside lab qPCR data were used as-is (as reported by each lab) in this 
manuscript, with the exception of BLOQ samples. For outside labs that reported BLOQ 
as quantified copy numbers or non-detects, a LLOQ was determined from their reported 
standard curves and BLOQ samples were treated as DNQ (see also Section 2 below). 
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Table S1. SOPs for quantitative and conventional PCR used by core SIPP laboratories.  dNTP = 
deoxynucleoside triphosphate, rxn = reaction, BSA = bovine serum albumin. (see attached Excel 
file) 
 
Table S2. Ordering information for (q)PCR reagents used by core SIPP labs 
Item Manufacturer Part number Specifications Vendor 
Primers Operon N/A 
resuspend in DNase-free 
water 
Operon 
Probes Operon N/A 
resuspend in TE pH 8.0 
(from MoBio), put in as 
many 1000 pmol 
aliquots as possible 
Operon 
qPCR MM 
Applied 
Biosystems 
4318157 AB Universal MM 
Life 
Technologies 
Conventional Takara RR001AM MgCl2 separate  
BSA GIBCO 15260-037  Invitrogen 
DNAse free water MoBio 100371-020  VWR 
qPCR core kit for 
SYBR® Assay 
ROX 
Eurogentec RT-SN10-05  Anaspec.com 
AE Buffer Qiagen 19077  Qiagen 
 
 
1.2. FlashGel System SOP 
All conventional PCR products were visualized using Lonza FlashGel 16+1 double tier cassettes 
(2.2% agarose gel, VWR cat# 95015-624). 
1. Remove the white seals on the gel cassette (leave the vent seals intact). 
2. Rinse the gel cassette with dI water (TAE buffer is acceptable as well) and remove any 
excess liquid from the gel cassette by tilting the cassette and blotting.  Do not touch the 
wells; they should have a bubble of liquid over them. 
3. Insert the cassette into the gel dock. 
4. Load samples by mixing 2uL sample with 2uL Lonza loading dye (5X loading dye VWR 
catalog number: 95015-630) and inject into well.  
5. Load 4uL of ladder (DNA marker (100bp-4kb) VWR catalog number: 95015-632) into one 
well (other size ladders can be used (i.e. 1kb); they all worked well in preliminary tests.    
6. Set the power source to 275V and allow the gel to run for ~3.5 minutes (Note: Single tier 
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cassettes can run up to 7 min and double tier cassettes up to 5 min). 
7. Pictures can be taken anytime during the gel electrophoresis and it is recommended to take 
one picture every minute since strong UV supply will potentially degrade PCR products.  
 
 
2. Variable assay performance across laboratories 
Table S3. Lower limit of quantification (LLOQ, in units of copies per filter) for each lab and 
assay. The lab “names” are random. BLOQ = below limit of quantification; DNQ = detected, not 
quantifiable; ND = not detected. Much of the information shown is a summary of data presented 
in Boehm et al. (this issue); the LLOQ values calculated in this work and not previously reported 
are shown in bold. 
Assay Lab 
Standard 
reference material 
LLOQ, 
copies/filter BLOQ reported 
BacH B Circular plasmid 230 DNQ 
BacHum-UCD 
A Circular plasmid 50 DNQ 
G Circular plasmid 644 DNQ 
H Circular plasmid 500 copy numbers 
J Circular plasmid 100 DNQ 
L Circular plasmid 3850 DNQ 
N Circular plasmid 2404 ND 
BsteriF1 
A Linear plasmid 50 DNQ 
G Linear plasmid 1857 DNQ 
J Linear plasmid 1000 DNQ 
M Linear plasmid 957 DNQ 
BtH F genomic DNA 700 DNQ 
gyrB D genomic DNA 20000 ND 
HF183 SYBR 
C Linear plasmid 250 DNQ 
E Synthesized oligo 100 DNQ 
G Linear plasmid 387 DNQ 
M Linear plasmid 991 DNQ 
HF183 Taqman 
A Linear plasmid 50 DNQ 
G Linear plasmid 2222 DNQ 
J Linear plasmid 1000 DNQ 
L Linear plasmid 2948 DNQ 
M Linear plasmid 1057 DNQ 
HumM2 
A Linear plasmid 50 DNQ 
G Linear plasmid 22486 DNQ 
H Linear plasmid 500 copy numbers 
J Linear plasmid 1000 DNQ 
L Linear plasmid 3407 DNQ 
M Linear plasmid 1113 DNQ 
Mnif 
G genomic DNA 2450 DNQ 
H genomic DNA 313 copy numbers 
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I genomic DNA 1000 copy numbers 
K genomic DNA 200 ND 
M genomic DNA 3282 DNQ 
 
Figure S1: Presence/absence sensitivity (top row) and specificity (bottom row) in singleton 
samples under both DNQ classifications (columns) in each lab. Some data are obscured by 
multiple points at the same location. The lab “names” are random. (see attached PDF) 
 
 
3. Variable DNA extraction yield among laboratories 
 
Figure S2(a). DNA yield according to DNA extraction kit and quantification method for all labs 
involved in the method evaluation study (Boehm et al., this issue). Note that the two laboratories 
that used a MoBio kit and a Qubit fluorometer reported lower DNA yield than all other labs. (see 
attached PDF) 
 
Figure S2(b).  DNA yield among labs measured by NanoDrop. The lab “names” in this figure are 
random. (see attached PDF) 
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4. Table 4 (main text) recreated with human stool and wastewater (sewage/septage) target sources considered separately 1 
Table S4. Human-associated marker abundance under all available fecal source characterizations. Values are median (standard 2 
deviation) of log10-transformed copy numbers across all labs. See footnotes to Table 4. The assay with the highest gene copy 3 
abundance in a target source (most sensitive) for each unit of measure is shown in bold. The assay with the lowest copy abundance 4 
in non-human sources (most specific) is shaded. Note that this definition of “specific” is different than what is used in Table 4. 5 
Assay Source n MgWet DNA 
ENT 
MF 
ENT 
qPCR 
E. coli 
MF 
E. coli 
qPCR GenBac AllBac BacUni Bfrag FecalB 
BacH 
human stool 4 7.5 (0.2) 5 (0.4) 4.8 (0.2) – 1.5 (0.2) 1 (0.2) – – – – – 
wastewater 8 – 1.5 (0.9) 1.7 (1) – 1.3 (1.1) 0.2 (1) – – – – – 
non-human 26 2.8 (0.9) 0.9 (0.9) -1.5 (1.8) – -1.5 (1.2) -2.2 (0.9) – – – – – 
BacHum-UCD 
human stool 24 7.1 (1) 4.8 (1.2) 4.4 (1) 2.3 (0.4) 1.1 (1) 0.6 (1) -1 (0.3) – -0.4 (0.1) – – 
wastewater 48 – 2.1 (1) 2.5 (0.9) -0.7 (0.4) 2.3 (1) 1 (0.9) -1.3 (0.4) – -0.4 (0.2) – – 
non-human 156 2.4 (1.7) 0 (1.7) -0.6 (1.3) -2.9 (1.3) -1.3 (1.8) -2.2 (1.7) -3.9 (1.9) – -3.8 (2.3) – – 
BsteriF1 
human stool 16 6.8 (0.2) 4.6 (0.2) 4.2 (0.2) 2.4 (0.4) 0.9 (0.2) 0.4 (0.2) -1.2 (0.3) – – – – 
wastewater 32 – 1.7 (0.5) 2.1 (0.4) -0.9 (0.5) 1.7 (0.6) 0.6 (0.4) -1.8 (0.4) – – – – 
non-human 104 2.9 (2) 0.8 (2) 0.7 (1.4) -1.8 (2.1) -1.3 (2) -2.2 (2.1) -3.6 (1.8) – – – – 
BtH 
human stool 4 5.3 (0.1) 3 (0.2) 2.6 (0.1) 2.8 (0.5) -0.7 (0.1) -1.2 (0.1) – – – – – 
wastewater 8 – 0.6 (0.8) 1.1 (0.5) -0.5 (0.8) 0.8 (0.7) -0.4 (0.4) – – – – – 
non-human 26 0.9 (0.7) -0.9 (0.4) -1.1 (1.2) -2.8 (1.2) -3.7 (1.6) -4.3 (1.2) – – – – – 
gyrB 
human stool 4 5.2 (0.3) 3.2 (0.1) 2.6 (0.3) – -0.7 (0.3) -1.2 (0.3) – – – -1.7 (0.7) – 
wastewater 8 – 0.9 (0.9) 0.8 (0.5) – 0.2 (0.4) -0.5 (0.6) – – – -2.2 (0.7) – 
non-human 26 1.2 (0.8) -0.3 (0.6) -0.9 (1.5) – -2.8 (1.1) -3.5 (0.8) – – – -3.4 (1.2) – 
HF183 SYBR 
human stool 16 5.9 (1.1) 3.7 (0.8) 3.3 (1.1) 1.4 (1.5) 0 (1.1) -0.6 (1.1) -2.5 (1.1) -2 (0.2) – – -1 (0.5) 
wastewater 32 – 1.3 (0.8) 1.4 (1.2) -1.2 (0.7) 1 (1.3) 0 (1.2) -2.1 (0.6) -2.1 (0.3) – – -1.6 (0.5) 
non-human 104 2.3 (1) -0.2 (0.8) -0.9 (1.4) -3.7 (1.3) -2.1 (1.4) -3.2 (1.3) -5.4 (1.9) -5.1 (NA) – – NA (NA) 
HF183 Taqman 
human stool 20 6.9 (0.1) 4.6 (0.2) 4.3 (0.1) 2.5 (0.6) 1 (0.1) 0.5 (0.1) -1.1 (0.4) – – – – 
wastewater 40 – 1.7 (0.7) 2.1 (0.5) -0.6 (0.9) 1.6 (0.6) 0.7 (0.4) -1.8 (0.6) – – – – 
non-human 130 1.2 (0.9) -0.5 (0.8) -1.1 (1.5) -4 (1.3) -2.8 (1.4) -3.2 (1.1) -5.1 (2.1) – – – – 
HumM2 
human stool 24 5.3 (0.3) 3 (0.5) 2.6 (0.3) 0.9 (0.4) -0.7 (0.3) -1.2 (0.3) -2.7 (0.3) – – – – 
wastewater 48 – 0.5 (0.7) 0.8 (0.4) -2.3 (1) 0.4 (0.5) -0.5 (0.5) -3 (0.8) – – – – 
non-human 156 0.8 (0.9) -1.1 (0.7) -0.9 (0.8) -3.7 (1.3) -2.6 (1.2) -3.2 (0.7) -6.2 (1.9) – – – – 
Mnif 
human stool 20 5.7 (0.5) 3.3 (0.7) 3.1 (0.5) 0.8 (0.5) -0.3 (0.5) -0.8 (0.5) -2.5 (0.5) – – – – 
wastewater 40 – 0.1 (0.9) 1.5 (1) -3.3 (0.6) 1.2 (1.1) -0.1 (0.9) -3.5 (0.6) – – – – 
non-human 130 3.4 (1.2) 0.8 (1.3) 1.6 (2.2) -1.9 (2.2) -0.7 (1.9) -1.3 (1.7) -4.5 (1.3) – – – – 
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5. Abundance of general qPCR gene copies per ng total DNA 6 
 7 
Figure S3: General assay copy abundance normalized by total DNA mass. Each point is the 8 
median value for a given fecal source, and the bars represent the interquartile ranges (25
th
 to 9 
75
th
 percentiles). Fecal sources are indicated by a unique combination of color and shape. 10 
The number in parenthesis after the assay name is the number of labs that ran the assay. The 11 
fecal Bacteroides qPCR assay data are excluded because no filter-matched NanoDrop total 12 
DNA measurements were available. 13 
 14 
 15 
6. Bacteroides 16S rRNA gene and oligonucelotide sequence analysis 16 
6.1. Goal: to examine each Bacteroides 16S rRNA gene assay’s in silico specificity by 17 
comparing the primer and probe sequences with the human and non-human Bacteroides 18 
16S rRNA reference gene sequences available in the National Center for Biotechnology 19 
Information (NCBI) database. 20 
 21 
6.2. Bacteroides primer/probe sequence analysis methods 22 
All data analyses were conducted in Geneious Pro 5.6.3 (Drummond et al., 2012). We used 23 
sequence data available from NCBI (the Gene and Nucleotide databases, accessed via Geneious 24 
on June 12, 2012) to examine the sequence specificity of the Bacteroides 16S rRNA gene assays. 25 
The primers and probes were aligned with 1) the reference sequences used to develop the assays, 26 
2) the sequences corresponding to accession numbers reported in the assay developers’ papers 27 
and 3) 75 other human-associated Bacteroides spp. 16S rRNA sequences, including those from 28 
fully sequenced genomes and ATCC reference type strains. The database was also searched for 29 
non-human fecal Bacteroides 16S rRNA sequences corresponding to the fecal sources used in 30 
the challenge filter samples. The primers and probes were tested for specificity against the non-31 
human sequences, with a maximum of 2 base mismatches allowed. 32 
 33 
6.3. Primer/probe alignment and mismatch results 34 
The alignment of human fecal-associated Bacteroides 16S rRNA gene sequences submitted by 35 
the assay developers’ labs with the related primers and probes reveal a fair amount of overlap in 36 
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the amplicon regions of these assays (Figure S4). For example, the positions of the BacHum-37 
UCD and forward and reverse primers are nearly identical to the HF183 SYBR primers. Indeed, 38 
the following primer/probes overlap one another within the same 71-bp region: BacH-pC, BacH-39 
pT, HF183F, BacHum160f, BsteriF1DE, BacHr, and BacHum193p (see Table 1 for oligo 40 
naming conventions, taken from the original publication of the assays whenever possible). The 41 
most unique primers and probes – those with no overlap with any other oligo in the alignment – 42 
are BacHf, BthetP1, BthetR1, and Bac708R. While previously the Bacteroides species associated 43 
with the HF183 marker was unknown (Bernhard and Field, 2000a), it now appears that all of the 44 
above assays except BsteriF1 target B. dorei  (Figure S4).   45 
 46 
The sequence specificity of each primer and probe was tested against all available non-human 47 
fecal-associated Bacteroides 16S rRNA gene sequences (n = 645) that corresponded to the fecal 48 
hosts in this study. These data included sequences from cow (n=40), chicken (65), dog (74), 49 
goose (110), gull (324), horse (19) and pig (13) hosts. Note that no sequences were found for 50 
pigeon or deer. A maximum of two base pair mismatches was allowed in the analysis. The 51 
BthetP1, BthetR1, HFsybR, BacHum241r and Bac708R sequences clearly target conserved 52 
regions of the 16S gene; these oligos had in silico binding – often without any mismatches – in 53 
the vast majority of non-human animal sequences (summarized in Table S3). Thus it is the 54 
forward primers that confer human specificity for these assays (BacHum-UCD, BsteriF1, HF183 55 
Taqman, HF183 SYBR and HF183 endpoint). The HF183F and BacHum160f primers matched 56 
only one cow sequence, with two mismatches on the 3’ end. The BsteriF1 forward primer 57 
matched one cow and one dog sequence, each with one mismatch on the 3’ end. The BacH assay 58 
had the most specific primer/probe set according to this analysis: the forward primer and both 59 
probes matched a few cow (n=2), dog (7) and gull (2) sequences, while the reverse primer had no 60 
nonspecific matches at all. Accordingly, BacH also had the least cross-reactivity to the non-61 
human challenge samples (Figure 1). Unfortunately there were not enough fecal-associated 62 
sequences in the database to perform similar analyses for the functional gene assays (BtH, gyrB, 63 
HumM2, Mnif). 64 
 65 
6.4. Primer/probe mismatch discussion 66 
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The most distinguishing feature of every PCR-based assay is the DNA sequences of the primers 67 
and probes, which play an important role in the host-specificity and sensitivity of the assay. All 68 
of the Bacteroides 16S rRNA gene-based assays in this study targeted the exact same region of 69 
the gene – originally identified by Bernhard & Field (2000b; 2000a) – and several assays shared 70 
nearly identical primer and probe regions (Figure S4). Given these similarities, one might expect 71 
the assays to perform in a similar, if not identical fashion, but this was not quite the case. 72 
Performance differences among nearly-identical assays can be due to annealing temperature, salt 73 
concentration, mastermix chemistry, thermalcycler platform, and so forth. The finding that in 74 
silico the probe and reverse primer of HF183 Taqman assay showed binding with hundreds of 75 
non-human sequences, yet was one of the most specific assays in the study, indicates that the 76 
HF183 forward primer is robustly human-associated. The conserved nature of the reverse primer 77 
and probe regions may also contribute to the increased sensitivity that HF183 enjoys.  78 
 79 
While there were some parallels between the in silico sequence matching and the qPCR results 80 
(e.g. BsteriF1 and dog), we expected to see more matches between the oligonucleotides and non-81 
human sequences given the number of hosts that showed cross-reactivity. However, this analysis 82 
was limited by the number of non-human sequences available in the NCBI database. For 83 
example, we were not able to compare any sequences from deer. This is unfortunate, as deer was 84 
a source of false-positive results for every assay, sometimes at levels equivalent to sewage or 85 
septage (Figure 1). Some contamination was detected in a small percentage of filter blanks and 86 
sample processing controls (see Boehm et al., SI), so it may be that the deer samples were 87 
contaminated with a human source during the sample collection or creation process. As such, it 88 
would have been ideal to sequence the amplicons from reactions that generated false positive 89 
results had we had unlimited resources. 90 
91 
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Table S5: Summary of nonspecific in silico primer binding (≤2 mismatches) in Bacteroides 16S 92 
rRNA gene-based assays 93 
 94 
Assay Oligonucleotide Match 
BacH 
BacHf Gull, Cow, Dog 
BacH-pC/BacH-pT Gull, Dog, Cow 
BacHr N/A 
BacHum-
UCD 
BacHum160f Cow 
BacHum193p Pig, Gull, Goose, Dog, Cow, Chicken 
BacHum241r Pig, Horse, Gull, Goose, Dog, Cow, Chicken 
BsteriF1 
BsteriF1DE Dog, cow 
BthetP1 Pig, Horse, gull goose, dog, cow, chicken 
BthetR1 Pig, Horse, gull goose, dog, cow, chicken 
HF183 
Taqman 
HF183F Cow 
BthetP1 Pig, Horse, gull goose, dog, cow, chicken 
BthetR1 Pig, Horse, gull goose, dog, cow, chicken 
HF183 
SYBR 
HF183F Cow 
HFsybR Pig, Horse, gull goose, dog, cow, chicken 
HF183 
endpoint 
HF183F Cow 
Bac708R Pig, horse, gull, goose, dog, cow, chicken 
 95 
 96 
Figure S4. Unique human-associated Bacteroides 16S rRNA gene sequences from NCBI 97 
(including assay developers’ sequences and reference genomes) aligned with the primers and 98 
probes used in this study over the region of the assay amplicons. The sequence that the original 99 
HF183 assay was based on (Accession # AF233408) was used as the reference sequence in the 100 
alignment. (see attached PDF) 101 
 102 
103 
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7. Positive and negative predictive values 104 
 105 
In addition to sensitivity and specificity, positive and negative predictive values (PPV and NPV) 106 
were calculated under both DNQ classifications each assay (singletons only). PPV and NPV 107 
were defined as: PPV = true positives/(true positives + false positives) and NPV = true 108 
negatives/(true negatives + false negatives). All three target sources (human stools, sewage and 109 
septage) were counted as true positives. These metrics responded similarly to the different 110 
classifications of DNQ samples as sensitivity and specificity (Table S4). Applying the same 80% 111 
criteria as used for sensitivity and specificity, only HF183 endpoint met the benchmark for PPV 112 
with DNQ positive. However, with DNQ negative, five assays met the 80% mark for PPV: BtH, 113 
gyrB, HF183 SYBR, HF183 Taqman, and HumM2. All assays met or exceeded 80% for NPV 114 
under both DNQ classifications. It is important to recognize that the PPV and NPV metrics are 115 
valid only for this dataset and cannot be extrapolated to environmental samples, because our 116 
challenge filter set does not reflect the prevalence of human fecal contamination found in the 117 
environment (Altman and Bland, 1994).  118 
 119 
 120 
Table S6. Positive and negative predictive values of the singletons calculated with DNQ samples 121 
treated as positive or negative. 122 
Assay n 
Positive predictive value Negative predictive value 
DNQ+ DNQ- DNQ+ DNQ- 
BacH 38 67% 69% 100% 88% 
BacHum-UCD 228 41% 58% 97% 98% 
BsteriF1 152 45% 53% 100% 97% 
BtH 38 50% 92% 100% 96% 
gyrB 38 50% 86% 94% 81% 
HF183 endpoint 266 90% NA 89% NA 
HF183 SYBR 152 68% 80% 100% 96% 
HF183 Taqman 190 46% 84% 100% 98% 
HumM2 228 63% 84% 96% 86% 
Mnif 190 53% 54% 87% 80% 
 123 
 124 
 125 
 126 
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Table S1. SOPs for quantitative and conventional PCR conditions used by "core" SIPP laboratories.  dNTP = deoxynucleoside triphosphate, rxn = reaction, BSA = bovine serum albumin. See Table S2 for vendor information
Assay
Developer 
reference Target gene oligo names
Reference 
material 
(standards)
rxn 
volume 
(µl)
template 
DNA 
volume 
(µl per 
rxn)
Enzyme and buffer (units per 
rxn)
Mastermix 
additives 
(units per 
rxn)
F primer 
µM per 
rxn
R primer 
µM per 
rxn
Probe µM 
per rxn
thermal cycling 
conditions
Bio-Rad 
CFX96 
threshold 
setting
ABI 
StepOnePlus 
threshold 
setting
PCR product 
visualization
BacH1
Reischer et 
al. (2007)
Bacteroides 
16S
BacHf, BacH-pT, 
BacH-pC, BacHr plasmid 25 2
12.5 µl iQ Supermix, 
contains hot-start iTaq™ 
DNA polymerase, dNTPs and 
buffer
BSA 0.4 µg/µl 0.2 0.2 0.1
95ºC for 3 min, 
50 cycles of 
(95ºC for 15 
sec, 61ºC for 15 
sec, 72ºC for 45 
sec), read at 
61ºC anneal
N/A3 N/A3 N/A
BacHum-
UCD
Kildare et al. 
(2007)
Bacteroides 
16S
BacHum160f, 
BacHum193p, 
BacHum241r
plasmid 25 2
12.5 µl Applied Biosystems 
Taqman™ Universal 
Mastermix (cat# 4318157)
BSA 0.05 
mg/ml 0.4 0.4 0.08 AB-Uni
2 100 RFU 0.03 N/A
BsteriF1 Haugland et al. (2010)
B. stericoris 
16S
BsteriF1DE, 
BthetP1, BthetR1 plasmid 25 2
12.5 µl Applied Biosystems 
Taqman™ Universal 
Mastermix (cat# 4318157)
BSA 0.05 
mg/ml 1 1 0.08 AB-Uni 100 RFU 0.08 N/A
BtH1
Yampara-
Iquise et al. 
(2008)
B. thetaiota-
omiron a-1-
6 
mannanase
BtH-F, BtH-P, 
BtH-R
genomic B. 
thetaiota-
omicron 
DNA
20 2 10 µl LightCycler Taqman 480 Probe Master Mix (5X)
BSA 0.2 
mg/ml 0.2 0.2 0.1
95ºC for 15 min, 
45 cycles of 
(95ºC for 15 
sec, 60ºC for 1 
min, 72ºC for 5 
sec), 40ºC for 
30 sec, read 
during 72ºC 
step
N/A4 N/A4 N/A
gyrB1
Lee et al. 
(2010)
B. fragilis 
gyrB
Bf904F, 
Bf923MGB, 
Bf958R
genomic B. 
fragilis  DNA 25 5
12.5 µl Applied Biosystems 
Taqman™ Universal 
Mastermix (cat# 4318157)
N/A 0.5 0.5 0.25 AB-Uni N/A
automatic 
threshold 
determination
N/A
HF183 
endpoint
Bernhard & 
Field (2000)
Bacteroides 
16S HF183F, Bac708R plasmid 25 2
0.625 U TaKarRa ExTaq 
(cat# RR001AM), 2.5 µl 10X 
TaKaRa PCR buffer
 200 µM each 
dNTP, 2 mM 
MgCl2, 0.05 
mg/ml BSA
0.2 0.2 N/A
94ºC for 2 min, 
35 cycles of 
(94ºC for 30 
sec, 63ºC for 45 
sec, 72ºC for 45 
sec), 72ºC for 7 
min
N/A N/A
FlashGel, 
see SOP in 
Supp Info 
section 1.2. 
Correct 
product is 
525 bp
HF183 SYBR Seurinck et al. (2005)
Bacteroides 
16S HF183F, HFsybR plasmid 25 2
0.625 U Hot GoldStar DNA 
Polymerase from Eurogentec 
qPCR core kit for Sybr® 
Green I (cat #RT-SN10-05), 
2.5 µl Eurogentec real-time 
PCR 10X Buffer (MgCl2-free)
200 µM each 
dNTP, 2 mM 
MgCl2, 0.75 
µl Sybr® 
Green I
0.25 0.25 N/A
50ºC for 2 min, 
95ºC for 10 min, 
40 cycles of 
(95ºC for 30 
sec, 53ºC for 1 
min, 60ºC for 1 
min)
100 RFU 0.03
melt curve 
with 
ramping 
from 60-
94.8ºC at 
0.4ºC per 10 
sec
HF183 
Taqman
Haugland et 
al. (2010)
Bacteroides 
16S
HF183F, BthetP1, 
BthetR1 plasmid 25 2
12.5 µl Applied Biosystems 
Taqman™ Universal 
Mastermix (cat# 4318157)
BSA 0.05 
mg/ml 1 1 0.08 AB-Uni 100 RFU 0.08 N/A
HumM2 Shanks et al. (2009)
B. fragilis 
hypothetical 
protein 
BF3236
HumM2F, 
HumM2P, 
HumM2R
plasmid 25 2
12.5 µl Applied Biosystems 
Taqman™ Universal 
Mastermix (cat# 4318157)
BSA 0.05 
mg/ml 1 1 0.08 AB-Uni 100 RFU 0.08 N/A
Mnif Johnston et al. (2010)
Methanobre
vi-bacter 
smithii  nifH
Mnif202F, MnifP, 
Mnif353R
genomic M. 
smithii  DNA 25 2
12.5 µl of 2x Quantitect 
Mastermix (Qiagen cat# 
204343)
N/A 0.5 0.5 0.12
50ºC for 2 min, 
95ºC for 15 min, 
45 cycles of 
(95ºC for 1 sec 
then 50ºC for 1 
min)
100 RFU 0.03 N/A
3developer lab used Eppendorf Mastercycler® ep realplex (Eppendorf AG, Hamburg, Germany); threshold settings not reported.
4developer lab used Roche LightCycler 480 Real-Time PCR System; threshold settings not reported
1not run by core labs, SOP reported by developer lab
2AB-Uni: 50ºC for 2 min, 95ºC for 10 min, 40 cycles of (95ºC for 15 sec then 60ºC for 1 min)
SensDNQpos SensDNQneg
SpecDNQpos SpecDNQneg
Mnif
HumM2
HF183 Taqman
HF183 SYBR
HF183 endpoint
gyrB
BtH
BsteriF1
BacHum−UCD
BacH
Mnif
HumM2
HF183 Taqman
HF183 SYBR
HF183 endpoint
gyrB
BtH
BsteriF1
BacHum−UCD
BacH
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Figure S1: Presence/Absence Sensitivity & Specificity by Lab
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Figure S2(a): DNA yield by extraction and quantification methods
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Figure S2(b): NanoDrop−quantified DNA yield by lab
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Figure S3: General assay copy abundance per ng fecal DNA

